<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032025000200192</article-id>
<article-id pub-id-type="doi">10.35366/119491</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Progresión de sarcoma de Kaposi asociado a VIH en contexto de un síndrome de reconstitución inmune]]></article-title>
<article-title xml:lang="en"><![CDATA[Progression of AIDS-related Kaposi sarcoma as part of immune reconstitution inflammatory syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Abad]]></surname>
<given-names><![CDATA[Laura]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Juárez Mayor]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramón y Cajal Calvo]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Clínico Universitario Lozano Blesa Servicio de Medicina Interna ]]></institution>
<addr-line><![CDATA[Zaragoza ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Clínico Universitario Lozano Blesa Servicio de Nefrología ]]></institution>
<addr-line><![CDATA[Zaragoza ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Clínico Universitario Lozano Blesa Servicio de Radiodiagnóstico ]]></institution>
<addr-line><![CDATA[Zaragoza ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>23</volume>
<numero>2</numero>
<fpage>192</fpage>
<lpage>194</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032025000200192&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032025000200192&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032025000200192&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  el sarcoma de Kaposi (SK) es un tumor angiomatoso maligno de afectación mucocutánea asociado al VIH. Se presenta con menos de 200 linfocitos CD4.  Caso clínico:  varón de 40 años VIH positivo y SK al diagnóstico que abandona tratamiento antirretroviral (TAR). Cuatro años después presenta progresión de las lesiones cutáneas con extensión hasta raíz de muslos y genitales tras reiniciar TAR.  Conclusión:  el síndrome inflamatorio de reconstitución inmune (SIRI) consiste en la activación o empeoramiento paradójico de infecciones oportunistas latentes con mejoría de la situación inmunológica. La incidencia de SK asociado a SIRI se sitúa en un 7%. El tratamiento consiste en mantener TAR, añadiendo quimioterapia en casos de enfermedad avanzada o del alto riesgo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Kaposi sarcoma (KS) is a malignant angiomatous tumor of mucocutaneous involvement associated with HIV. It presents with less than 200 CD4 lymphocytes.  Clinical case:  a 40-year-old HIV-positive man with KS at diagnosis who abandons antiretroviral treatment (ART). Four years later, the patient presented a progression of skin lesions to the thighs and genitals after restarting ART.  Conclusion:  Immune reconstitution syndrome (IRIS) consists of the paradoxical activation or worsening of latent opportunistic infections while improving the immunological situation. The incidence of KS associated with IRIS is 7%. Treatment consists of maintaining ART and adding chemotherapy in severe cases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[sarcoma de Kaposi]]></kwd>
<kwd lng="es"><![CDATA[síndrome inflamatorio de reconstitución inmune]]></kwd>
<kwd lng="es"><![CDATA[infecciones por VIH]]></kwd>
<kwd lng="es"><![CDATA[recuento de linfocitos CD4]]></kwd>
<kwd lng="es"><![CDATA[terapia antirretroviral altamente activa]]></kwd>
<kwd lng="en"><![CDATA[Kaposi sarcoma]]></kwd>
<kwd lng="en"><![CDATA[immune reconstitution inflammatory syndrome]]></kwd>
<kwd lng="en"><![CDATA[HIV infections]]></kwd>
<kwd lng="en"><![CDATA[CD4 lymphocyte count]]></kwd>
<kwd lng="en"><![CDATA[antiretroviral therapy highly active]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poizot-Martin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Brégigeon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Palich]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Marcelin]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Valantin]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Solas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immune reconstitution inflammatory syndrome associated Kaposi sarcoma]]></article-title>
<source><![CDATA[Cancers (Basel)]]></source>
<year>2022</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>986</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bower]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Thirlwell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Newsom-Davis]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mandalia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immune reconstitution inflammatory syndrome associated with Kaposi&#8217;s sarcoma]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2005</year>
<volume>23</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>5224-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reyes Corcho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bouza Jiménez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de reconstitución inmunológica asociado al virus de la inmunodeficiencia humana y sida. Estado del arte]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2010</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>110-21</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nyirenda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ngongondo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Umbleja]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Krown]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Godfrey]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early progression and immune reconstitution inflammatory syndrome during treatment of mild-to-moderate Kaposi sarcoma in Sub-Saharan Africa and South America: incidence, long-term outcomes, and effects of early chemotherapy]]></article-title>
<source><![CDATA[J Acquir Immune Defic Syndr]]></source>
<year>2020</year>
<volume>84</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>422-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wandel]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Colebunders]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Attia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Furrer]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Egger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2010</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>251-61</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández-Sánchez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Iglesias]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Ablanedo-Terrazas]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ormsby]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarado-de la Barrera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes-Terán]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Steroids are a risk factor for Kaposi&#8217;s sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection]]></article-title>
<source><![CDATA[AIDS]]></source>
<year>2016</year>
<volume>30</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>909-14</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
